United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-069_7aa24558-b2a2-ed22-b6bc-69a011d2511a
- Product NDC
- 70377-069
- Form
- TABLET
- Composition / generic term
- Everolimus
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250602
- Source listing expiry
- 20261231
Source-listed ingredients
- EVEROLIMUS — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (70377-069-11) · 70377-069-11
- 6 BLISTER PACK in 1 CARTON (70377-069-12) / 10 TABLET in 1 BLISTER PACK · 70377-069-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →